AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet

Feb 9 (Reuters) - AB Science SA ABS.PA:

• AB SCIENCE ANNOUNCED THAT THE FOOD AND DRUG ADMINISTRATION (FDA) GRANTED THE STATUS OF MINOR USE IN MAJOR SPECIES (MUMS) FOR MASIVET® IN THE TREATMENT OF CANINE MAST CELL TUMORS

• AB SCIENCE SA: IN CASE OF MASIVET APPROVAL IN USA, CO EXPECTS EBITDA GENERATED FROM ANIMAL HEALTH TO COVER PART OF ITS FIXED-COST STRUCTURE

• AB SCIENCE SA: DISCUSSING DISTRIBUTION AGREEMENTS FOR NEW REGIONS NOT YET COVERED